Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Metabolomic Classification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome via Explainable Ensemble Learning and Pareto-Guided Feature Selection.

International journal of molecular sciences·2026
Same author

Amplification Chambers and Belief Persistence in Commercial Health Communication.

Journal of health communication·2026
Same author

Fecal Extracellular Vesicle Metabolomics as a Non-Invasive Biomarker Source in Colorectal Cancer: TPOT AutoML Superiority over Tree-Based Models with SHAP and LIME Clinical Interpretability.

International journal of molecular sciences·2026
Same author

Explainable Boosting Machine in Sepsis Prediction Using Platelet Metabolomics: An Interpretable Machine Learning Approach.

Diagnostics (Basel, Switzerland)·2026
Same author

Acute Creatine Ingestion Before Resistance Training Enhances Strength Performance More than Ingestion During or After Training: A Randomized Crossover Pilot Trial.

Nutrients·2026
Same author

<i>ACTN3</i> rs1815739 and <i>BDNF</i> rs6265 Polymorphisms May Not Be Associated with Handgrip Strength in Elite Wrestlers.

Genes·2026

相关实验视频

Updated: Sep 18, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K

在乳腺癌诊断中用于血清基代谢的可解释机器学习:来自多目标特征选择驱动光GBM-SHAP模型的见解.

Emek Guldogan1, Fatma Hilal Yagin2, Hasan Ucuzal1

  • 1Department of Biostatistics, and Medical Informatics, Faculty of Medicine, Inonu University, 44280 Malatya, Turkey.

Medicina (Kaunas, Lithuania)
|June 27, 2025
PubMed
概括

这项研究使用先进的代谢学和可解释的人工智能 (XAI) 确定了用于乳腺癌检测的新型血清代谢生物标志物. 这些发现提高了诊断的准确性,并提供了对疾病进展的生物学见解.

关键词:
轻GBMM 轻GBMM 的时间这就是 SHAP SHAP 的意思.生物标志物 生物标志物乳腺癌 乳腺癌 乳腺癌诊断的准确性 诊断的准确性可以解释的人工智能AI代谢生物组的代谢生物组

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K

相关实验视频

Last Updated: Sep 18, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K

科学领域:

  • 代谢学 代谢学 代谢学
  • 机器学习 机器学习
  • 生物标志物发现发现

背景情况:

  • 乳腺癌是全球妇女死亡的主要原因.
  • 乳腺癌的传统生物标志物缺乏敏感性和特异性,特别是在早期阶段.
  • 代谢学和可解释的人工智能 (XAI) 为改善乳腺癌诊断提供了有希望的途径.

研究的目的:

  • 识别和验证基于血清的代谢生物标志物用于乳腺癌检测.
  • 通过先进的代谢分析和机器学习来提高诊断准确度.
  • 利用夏普利添加式解释 (SHAP) 来实现模型解释性和生物洞察力.

主要方法:

  • 用LC-TOFMS和GC-TOFMS分析了来自103名乳腺癌患者和31名对照患者的血清样本.
  • 用多目标特征选择 (MOFS) 进行了强大的生物标志物发现.
  • 使用SHAP分析的光梯度增强机 (LightGBM) 用于分类和代谢物重要性排名.

主要成果:

  • 在乳腺癌检测中,LightGBM实现了86.6%的准确度,89.1%的灵敏度和84.2%的特异性.
  • SHAP分析确定了2-氨基黄油酸,胆和甲酸作为关键的有影响力的代谢物.
  • 代谢物失调与乳腺癌风险显著相关.

结论:

  • 这项研究将SHAP可解释性与代谢学相结合,用于增强乳腺癌诊断.
  • 鉴定的生物标志物提高了诊断准确度,并揭示了与乳腺癌相关的代谢失调.
  • 将代谢学与XAI驱动的机器学习相结合,显示出临床采用的巨大潜力.